Winton Group LTD Harmony Biosciences Holdings, Inc. Transaction History

Winton Group LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$19.2 - $33.78 $1.1 Million - $1.94 Million	57,438 Added 474.77%	69,536 $2.25 Million
Q3 2023 Nov 13, 2023	SELL	$31.89 - $39.03 $22,163 - $27,125	-695 Reduced 5.43%	12,098 $396,000
Q2 2023 Aug 14, 2023	SELL	$30.5 - $37.4 $780,495 - $957,066	-25,590 Reduced 66.67%	12,793 $450,000
Q1 2023 May 12, 2023	BUY	$30.8 - $53.92 $502,317 - $879,381	16,309 Added 73.88%	38,383 $1.25 Million
Q4 2022 Feb 14, 2023	BUY	$45.4 - $60.91 $242,890 - $325,868	5,350 Added 31.99%	22,074 $1.22 Million
Q3 2022 Nov 10, 2022	BUY	$42.06 - $55.45 $253,075 - $333,642	6,017 Added 56.2%	16,724 $741,000
Q2 2022 Aug 10, 2022	BUY	$33.54 - $52.15 $359,112 - $558,370	10,707 New	10,707 $522,000
Q1 2022 May 11, 2022	SELL	$33.14 - $51.13 $229,726 - $354,433	-6,932 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$34.09 - $43.91 $236,311 - $304,384	6,932 New	6,932 $296,000

242

45.1M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.02B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.